153 related articles for article (PubMed ID: 36461154)
1. Mosaic RASopathies: A review of disorders caused by somatic pathogenic variants in the genes of the RAS/MAPK pathway.
Carli D; Resta N; Ferrero GB; Ruggieri M; Mussa A
Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):520-529. PubMed ID: 36461154
[TBL] [Abstract][Full Text] [Related]
2. Lateralized overgrowth with vascular malformation caused by a somatic PTPN11 pathogenic variant: Another piece added to the puzzle of mosaic RASopathies.
Mussa A; Turchiano A; Cardaropoli S; Coppo P; Pantaleo A; Bagnulo R; Ranieri C; Iacoviello M; Garganese A; Stella A; Vallero SG; Bertin D; Santoro F; Carli D; Ferrero GB; Resta N
Genes Chromosomes Cancer; 2022 Nov; 61(11):689-695. PubMed ID: 35778969
[TBL] [Abstract][Full Text] [Related]
3. Novel therapeutic perspectives in Noonan syndrome and RASopathies.
Saint-Laurent C; Mazeyrie L; Yart A; Edouard T
Eur J Pediatr; 2024 Mar; 183(3):1011-1019. PubMed ID: 37863846
[TBL] [Abstract][Full Text] [Related]
4. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.
Tidyman WE; Rauen KA
Curr Opin Genet Dev; 2009 Jun; 19(3):230-6. PubMed ID: 19467855
[TBL] [Abstract][Full Text] [Related]
5. Extracranial Vascular Anomalies Driven by RAS/MAPK Variants: Spectrum and Genotype-Phenotype Correlations.
Schmidt VF; Kapp FG; Goldann C; Huthmann L; Cucuruz B; Brill R; Vielsmeier V; Seebauer CT; Michel AJ; Seidensticker M; Uller W; Weiß JBW; Sint A; Häberle B; Haehl J; Wagner A; Cordes J; Holm A; Schanze D; Ricke J; Kimm MA; Wohlgemuth WA; Zenker M; Wildgruber M;
J Am Heart Assoc; 2024 Apr; 13(8):e033287. PubMed ID: 38563363
[TBL] [Abstract][Full Text] [Related]
6. Undiagnosed RASopathies in infertile men.
Juchnewitsch AG; Pomm K; Dutta A; Tamp E; Valkna A; Lillepea K; Mahyari E; Tjagur S; Belova G; Kübarsepp V; Castillo-Madeen H; Riera-Escamilla A; Põlluaas L; Nagirnaja L; Poolamets O; Vihljajev V; Sütt M; Versbraegen N; Papadimitriou S; McLachlan RI; Jarvi KA; Schlegel PN; Tennisberg S; Korrovits P; Vigh-Conrad K; O'Bryan MK; Aston KI; Lenaerts T; Conrad DF; Kasak L; Punab M; Laan M
Front Endocrinol (Lausanne); 2024; 15():1312357. PubMed ID: 38654924
[TBL] [Abstract][Full Text] [Related]
7. The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway.
Stevenson DA; Schill L; Schoyer L; Andresen BS; Bakker A; Bayrak-Toydemir P; Burkitt-Wright E; Chatfield K; Elefteriou F; Elgersma Y; Fisher MJ; Franz D; Gelb BD; Goriely A; Gripp KW; Hardan AY; Keppler-Noreuil KM; Kerr B; Korf B; Leoni C; McCormick F; Plotkin SR; Rauen KA; Reilly K; Roberts A; Sandler A; Siegel D; Walsh K; Widemann BC
Am J Med Genet A; 2016 Aug; 170(8):1959-66. PubMed ID: 27155140
[TBL] [Abstract][Full Text] [Related]
8. Mosaic RASopathies.
Hafner C; Groesser L
Cell Cycle; 2013 Jan; 12(1):43-50. PubMed ID: 23255105
[TBL] [Abstract][Full Text] [Related]
9. Study of Ras/MAPK pathway gene variants in Chilean patients with Cryptorchidism.
Rodríguez F; Vallejos C; Ponce D; Unanue N; Hernández MI; Célis S; Arcos K; Belmar F; López MT; Cassorla F
Andrology; 2018 Jul; 6(4):579-584. PubMed ID: 29752777
[TBL] [Abstract][Full Text] [Related]
10. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
Tidyman WE; Rauen KA
Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
[TBL] [Abstract][Full Text] [Related]
11. The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes.
Bezniakow N; Gos M; Obersztyn E
Dev Period Med; 2014; 18(3):285-96. PubMed ID: 25182392
[TBL] [Abstract][Full Text] [Related]
12. The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discovery.
Kontaridis MI; Roberts AE; Schill L; Schoyer L; Stronach B; Andelfinger G; Aoki Y; Axelrad ME; Bakker A; Bennett AM; Broniscer A; Castel P; Chang CA; Cyganek L; Das TK; den Hertog J; Galperin E; Garg S; Gelb BD; Gordon K; Green T; Gripp KW; Itkin M; Kiuru M; Korf BR; Livingstone JR; López-Juárez A; Magoulas PL; Mansour S; Milner T; Parker E; Pierpont EI; Plouffe K; Rauen KA; Shankar SP; Smith SB; Stevenson DA; Tartaglia M; Van R; Wagner ME; Ware SM; Zenker M
Am J Med Genet A; 2022 Jun; 188(6):1915-1927. PubMed ID: 35266292
[TBL] [Abstract][Full Text] [Related]
13. The sixth international RASopathies symposium: Precision medicine-From promise to practice.
Gripp KW; Schill L; Schoyer L; Stronach B; Bennett AM; Blaser S; Brown A; Burdine R; Burkitt-Wright E; Castel P; Darilek S; Dias A; Dyer T; Ellis M; Erickson G; Gelb BD; Green T; Gross A; Ho A; Holder JL; Inoue SI; Jelin AC; Kennedy A; Klein R; Kontaridis MI; Magoulas P; McConnell DB; McCormick F; Neel BG; Prada CE; Rauen KA; Roberts A; Rodriguez-Viciana P; Rosen N; Rumbaugh G; Sablina A; Solman M; Tartaglia M; Thomas A; Timmer WC; Venkatachalam K; Walsh KS; Wolters PL; Yi JS; Zenker M; Ratner N
Am J Med Genet A; 2020 Mar; 182(3):597-606. PubMed ID: 31825160
[TBL] [Abstract][Full Text] [Related]
14. The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway.
Tajan M; Paccoud R; Branka S; Edouard T; Yart A
Endocr Rev; 2018 Oct; 39(5):676-700. PubMed ID: 29924299
[TBL] [Abstract][Full Text] [Related]
15. First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics.
Rauen KA; Alsaegh A; Ben-Shachar S; Berman Y; Blakeley J; Cordeiro I; Elgersma Y; Evans DG; Fisher MJ; Frayling IM; George J; Huson SM; Kerr B; Khire U; Korf B; Legius E; Messiaen L; van Minkelen R; Nampoothiri S; Ngeow J; Parada LF; Phadke S; Pillai A; Plotkin SR; Puri R; Raji A; Ramesh V; Ratner N; Shankar SP; Sharda S; Tambe A; Vikkula M; Widemann BC; Wolkenstein P; Upadhyaya M
Am J Med Genet A; 2019 Jun; 179(6):1091-1097. PubMed ID: 30908877
[TBL] [Abstract][Full Text] [Related]
16. Ras/MAPK dysregulation in development causes a skeletal myopathy in an activating Braf
Maeda Y; Tidyman WE; Ander BP; Pritchard CA; Rauen KA
Dev Dyn; 2021 Aug; 250(8):1074-1095. PubMed ID: 33522658
[TBL] [Abstract][Full Text] [Related]
17. The RASopathies: from pathogenetics to therapeutics.
Hebron KE; Hernandez ER; Yohe ME
Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 35178568
[TBL] [Abstract][Full Text] [Related]
18. RAS diseases in children.
Niemeyer CM
Haematologica; 2014 Nov; 99(11):1653-62. PubMed ID: 25420281
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of sequence variants in the RAS-mitogen activated protein kinase signaling pathway in pre-adolescent children with hypertrophic cardiomyopathy.
Kaski JP; Syrris P; Shaw A; Alapi KZ; Cordeddu V; Esteban MT; Jenkins S; Ashworth M; Hammond P; Tartaglia M; McKenna WJ; Elliott PM
Circ Cardiovasc Genet; 2012 Jun; 5(3):317-26. PubMed ID: 22589294
[TBL] [Abstract][Full Text] [Related]
20. Proceedings of the fifth international RASopathies symposium: When development and cancer intersect.
Rauen KA; Schoyer L; Schill L; Stronach B; Albeck J; Andresen BS; Cavé H; Ellis M; Fruchtman SM; Gelb BD; Gibson CC; Gripp K; Hefner E; Huang WYC; Itkin M; Kerr B; Linardic CM; McMahon M; Oberlander B; Perlstein E; Ratner N; Rogers L; Schenck A; Shankar S; Shvartsman S; Stevenson DA; Stites EC; Stork PJS; Sun C; Therrien M; Ullian EM; Widemann BC; Yeh E; Zampino G; Zenker M; Timmer W; McCormick F
Am J Med Genet A; 2018 Dec; 176(12):2924-2929. PubMed ID: 30302932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
